Resultados de búsqueda - Eric Lipp
- Mostrando 1 - 18 Resultados de 18
-
1
-
2
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas por Vidyalakshmi Chandramohan, Jeffrey D. Bryant, Hailan Piao, Stephen T. Keir, Eric Lipp, Michaela Lefaivre, Kathryn Perkinson, Darell D. Bigner, Matthias Gromeier, Roger E. McLendon
Publicado 2017Artigo -
3
Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma por Ashley Ghiaseddin, David A. Reardon, Woody Massey, Alex Mannerino, Eric Lipp, James E. Herndon, Frances McSherry, Annick Desjardins, Dina Randazzo, Henry S. Friedman, Katherine B. Peters
Publicado 2017Artigo -
4
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma por Emil Lou, Katherine B. Peters, Ashley Sumrall, Annick Desjardins, David A. Reardon, Eric Lipp, James E. Herndon, April Coan, Leighann Bailey, Scott Turner, Henry S. Friedman, James J. Vredenburgh
Publicado 2013Artigo -
5
The genetic landscape of anaplastic astrocytoma por Patrick Killela, Christopher J. Pirozzi, Zachary J. Reitman, Siân Jones, B. Ahmed Rasheed, Eric Lipp, Henry S. Friedman, Allan H. Friedman, Yiping He, Roger E. McLendon, Darell D. Bigner, Hai Yan
Publicado 2013Artigo -
6
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma por David A. Reardon, Andrew D. Norden, Annick Desjardins, James J. Vredenburgh, James E. Herndon, April Coan, John H. Sampson, Sridharan Gururangan, Katherine B. Peters, Roger E. McLendon, J. Norfleet, Eric Lipp, Jan Drappatz, Patrick Y. Wen, Henry S. Friedman
Publicado 2011Artigo -
7
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients por David A. Reardon, James E. Herndon, Katherine B. Peters, Annick Desjardins, April Coan, Emil Lou, Ashley Sumrall, Scott Turner, Eric Lipp, Sith Sathornsumetee, Jeremy N. Rich, John H. Sampson, Allan H. Friedman, Susan Boulton, Darell D. Bigner, Henry S. Friedman, James J. Vredenburgh
Publicado 2012Artigo -
8
Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial por Eric M. Thompson, Daniel Landi, Michael C. Brown, Henry S. Friedman, Roger E. McLendon, James E. Herndon, Evan Buckley, Dani P. Bolognesi, Eric Lipp, Kristin Schroeder, Oren J. Becher, Allan H. Friedman, Zachary P. McKay, Ashley A. Walter, Stevie Threatt, Denise Jaggers, Annick Desjardins, Matthias Gromeier, Darell D. Bigner, David M. Ashley
Publicado 2023Artigo -
9
Mutations in <i>IDH1</i>, <i>IDH2</i>, and in the <i>TERT</i> promoter define clinically distinct subgroups of adult malignant gliomas por Patrick Killela, Christopher J. Pirozzi, Patrick Healy, Zachary J. Reitman, Eric Lipp, B. Ahmed Rasheed, Rui Yang, Bill H. Diplas, Zhaohui Wang, Paula K. Greer, Huishan Zhu, Catherine Y. Wang, Austin B. Carpenter, Henry S. Friedman, Allan H. Friedman, Stephen T. Keir, Jie He, Yiping He, Roger E. McLendon, James E. Herndon, Hai Yan, Darell D. Bigner
Publicado 2014Artigo -
10
Morphological and molecular features of astroblastoma, including<i>BRAFV600E</i>mutations, suggest an ontological relationship to other cortical-based gliomas of children and young... por Norman L. Lehman, Eyas M. Hattab, Bret C. Mobley, Aisulu Usubalieva, Matthew Schniederjan, Roger E. McLendon, Werner Paulus, Elisabeth J. Rushing, Maria-Magdalena Georgescu, Marta Couce, Mohanpal Dulai, Mark L. Cohen, Christopher R. Pierson, Jack Raisanen, Sarah E. Martin, Trang D. Lehman, Eric Lipp, José M. Bonnin, Mousa A. Al‐Abbadi, Kara Kenworthy, Kevin Zhao, Nehad Mohamed, Guojuan Zhang, Weiqiang Zhao
Publicado 2016Artigo -
11
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma por Bill H. Diplas, Xujun He, Jacqueline A. Brosnan‐Cashman, Heng Liu, Lee H. Chen, Zhaohui Wang, Casey J. Moure, Patrick Killela, Daniel B. Loriaux, Eric Lipp, Paula K. Greer, Rui Yang, Anthony Rizzo, Fausto J. Rodríguez, Allan H. Friedman, Henry S. Friedman, Sizhen Wang, Yiping He, Roger E. McLendon, Darell D. Bigner, Yuchen Jiao, Matthew S. Waitkus, Alan K. Meeker, Hai Yan
Publicado 2018Artigo -
12
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy por Matthias Gromeier, Michael C. Brown, Gao Zhang, Xiang Lin, Yeqing Chen, Zhi Wei, Nike Beaubier, Hai Yan, Yiping He, Annick Desjardins, James E. Herndon, Frederick S. Varn, Roel G.W. Verhaak, Junfei Zhao, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Andrea Muscat, Eric Lipp, Smita K. Nair, Mustafa Khasraw, Katherine B. Peters, Dina Randazzo, John H. Sampson, Roger E. McLendon, Darell D. Bigner, David M. Ashley
Publicado 2021Artigo -
13
Frequent <i>ATRX</i>, <i>CIC</i>, <i>FUBP1</i> and <i>IDH1</i> mutations refine the classification of malignant gliomas por Yuchen Jiao, Patrick Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodríguez, Sérgio Rosemberg, Sueli Mieko Oba‐Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. López, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter C. Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Díaz, Hai Yan
Publicado 2012Artigo -
14
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis por Vijay Ramaswamy, Marc Remke, Éric Bouffet, Cláudia C. Faria, Sébastien Perreault, Yoon-Jae Cho, David Shih, Betty Luu, Adrian M. Dubuc, Paul A. Northcott, Ulrich Schüller, Sridharan Gururangan, Roger E. McLendon, Darell D. Bigner, Maryam Fouladi, Keith L. Ligon, Scott L. Pomeroy, Sandra E. Dunn, Joanna Triscott, Nada Jabado, Adam M. Fontebasso, David Jones, Marcel Kool, Matthias A. Karajannis, Sharon L. Gardner, David Zagzag, Sofia Nunes, José Pimentel, Jaume Mora, Eric Lipp, Andrew W. Walter, Marina Ryzhova, Olga Zheludkova, Э. В. Кумирова, Jad Alshami, Sidney Croul, James T. Rutka, Cynthia Hawkins, Uri Tabori, Kari-Elise Codispoti, Roger J. Packer, Stefan M. Pfister, Andrey Korshunov, Michael D. Taylor
Publicado 2013Artigo -
15
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy por Kirsten A. White, Kate Connor, Maxime Meylan, Antoine Bougoüin, Manuela Salvucci, Franck Bielle, Alice C. O’Farrell, Kieron J. Sweeney, Lihong Weng, Gabriele Bergers, Patrick Dicker, David M. Ashley, Eric Lipp, Justin Low, Junfei Zhao, Pengbo Wen, Robert M. Prins, Maïté Verreault, Ahmed Idbaïh, Antara Biswas, Jochen H.M. Prehn, Diether Lambrechts, Ingrid Arijs, Francesca Lodi, Gonca Dilcan, Martine L.M. Lamfers, Sieger Leenstra, Federica Fabro, Ioannis Ntafoulis, Johan M. Kros, Jane Cryan, Francesca M. Brett, Emie Quissac, Alan Beausang, Steve MacNally, Philip J. O’Halloran, James Clerkin, Orna Bacon, Andreas Kremer, Romain Tching Chi Yen, Frederick S. Varn, Roel G.W. Verhaak, Catherine Sautès‐Fridman, Wolf H. Fridman, Annette T. Byrne
Publicado 2022Artigo -
16
Heterogeneity within the PF-EPN-B ependymoma subgroup por Florence M.G. Cavalli, Jens-Martin Hübner, Tanvi Sharma, Betty Luu, Martin Sill, Michal Zápotocký, Stephen C. Mack, Hendrik Witt, Tong Lin, David Shih, Ben Ho, Mariarita Santi, Lyndsey Emery, Juliette Hukin, Christopher Dunham, Roger E. McLendon, Eric Lipp, Sridharan Gururangan, Andrew J. Grossbach, Pim J. French, Johan M. Kros, Marie‐Lise C. van Veelen, Amulya A. Nageswara Rao, Caterina Giannini, Sarah Leary, Shin Jung, Cláudia C. Faria, Jaume Mora, Ulrich Schüller, Marta M. Alonso, Jennifer A. Chan, Álmos Klekner, Lola B. Chambless, Eugene Hwang, Maura Massimino, Charles G. Eberhart, Matthias A. Karajannis, Benjamin Y. Lu, Linda M. Liau, Massimo Zollo, Veronica Ferrucci, Carlos Gilberto Carlotti, Daniela Pretti da Cunha Tirapelli, Uri Tabori, Éric Bouffet, Marina Ryzhova, David W. Ellison, Thomas E. Merchant, Mark R. Gilbert, Terri S. Armstrong, Andrey Korshunov, Stefan M. Pfister, Michael D. Taylor, Kenneth Aldape, Kristian W. Pajtler, Marcel Kool, Vijay Ramaswamy
Publicado 2018Artigo -
17
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis por Eric M. Thompson, Thomas Hielscher, Éric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E. McLendon, Darell D. Bigner, Eric Lipp, Sébastien Perreault, Yoon-Jae Cho, Gerald A. Grant, Seung-Ki Kim, Ji Yeoun Lee, Amulya A. Nageswara Rao, Caterina Giannini, Kay Ka Wai Li, Ho‐Keung Ng, Yu Yao, Toshihiro Kumabe, Teiji Tominaga, Wiesława Grajkowska, Marta Perek‐Polnik, David C.Y. Low, Wan Tew Seow, Kenneth Tou En Chang, Jaume Mora, Ian F. Pollack, Ronald L. Hamilton, Sarah Leary, Andrew S. Moore, Wendy J. Ingram, Andrew R. Hallahan, Anne Jouvet, Michelle Fèvre‐Montange, Alexandre Vasiljevic, Cécile Faure‐Conter, Tomoko Shofuda, Naoki Kagawa, Naoya Hashimoto, Nada Jabado, Alexander G. Weil, Tenzin Gayden, Takafumi Wataya, Tarek Shalaby, Michael Grotzer, Karel Zitterbart, Jaroslav Štěrba, Leoš Křen, Tibor Hortobágyi, Álmos Klekner, László Bognár, Tímea Pócza, Péter Hauser, Ulrich Schüller, Shin Jung, Woo-Youl Jang, Pim J. French, Johan M. Kros, Marie‐Lise C. van Veelen, Luca Massimi, Jeffrey R. Leonard, Joshua B. Rubin, Rajeev Vibhakar, Lola B. Chambless, Michael K. Cooper, Reid C. Thompson, Cláudia C. Faria, Alice Carvalho, Sofia Nunes, José Pimentel, Xing Fan, Karin M. Muraszko, Enrique López‐Aguilar, David Lyden, Livia Garzia, David Shih, Noriyuki Kijima, Christian Schneider, Jennifer Adamski, Paul A. Northcott, Marcel Kool, David Jones, Jennifer A. Chan, Ana Nikolić, Maria Luisa Garrè, Erwin G. Van Meir, Satoru Osuka, Jeffrey J. Olson, Arman Jahangiri, Brandyn Castro, Nalin Gupta, William A. Weiss, Iska Moxon‐Emre, Donald Mabbott, Álvaro Lassaletta, Cynthia Hawkins, Uri Tabori, James M. Drake, Abhaya V. Kulkarni
Publicado 2016Artigo -
18
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis por Vijay Ramaswamy, Thomas Hielscher, Stephen C. Mack, Álvaro Lassaletta, Tong Lin, Kristian W. Pajtler, David Jones, Betty Luu, Florence M.G. Cavalli, Kenneth Aldape, Marc Remke, Martin Mynarek, Stefan Rutkowski, Sridharan Gururangan, Roger E. McLendon, Eric Lipp, Christopher Dunham, Juliette Hukin, David D. Eisenstat, Dorcas Fulton, Frank K.H. van Landeghem, Mariarita Santi, Marie‐Lise C. van Veelen, Erwin G. Van Meir, Satoru Osuka, Xing Fan, Karin M. Muraszko, Daniela Pretti da Cunha Tirapelli, Sueli Mieko Oba‐Shinjo, Suely Kazue Nagahashi Marie, Carlos Gilberto Carlotti, Ji Yeoun Lee, Amulya A. Nageswara Rao, Caterina Giannini, Cláudia C. Faria, Sofia Nunes, Jaume Mora, Ronald L. Hamilton, Péter Hauser, Nada Jabado, Kevin Petrecca, Shin Jung, Luca Massimi, Massimo Zollo, Giuseppe Cinalli, László Bognár, Álmos Klekner, Tibor Hortobágyi, Sarah Leary, Ralph Ermoian, James M. Olson, Jeffrey R. Leonard, Corrine Gardner, Wiesława Grajkowska, Lola B. Chambless, Jason Cain, Charles G. Eberhart, Sama Ahsan, Maura Massimino, Felice Giangaspero, Francesca Romana Buttarelli, Roger J. Packer, Lyndsey Emery, William H. Yong, Horacio Soto, Linda M. Liau, Richard G. Everson, Andrew J. Grossbach, Tarek Shalaby, Michael Grotzer, Matthias A. Karajannis, David Zagzag, Helen Wheeler, Katja von Hoff, Marta M. Alonso, T. Tuñón, Ulrich Schüller, Karel Zitterbart, Jaroslav Štěrba, Jennifer A. Chan, Miguel A. Guzmán, Samer K. Elbabaa, Howard Colman, Girish Dhall, Paul G. Fisher, Maryam Fouladi, Amar Gajjar, Stewart Goldman, Eugene Hwang, Marcel Kool, Harshad Ladha, Elizabeth Vera‐Bolanos, Khalida Wani, Frank S. Lieberman, Tom Mikkelsen, Antonio Omuro, Ian F. Pollack, Michael D. Prados, H. Ian Robins, Riccardo Soffietti
Publicado 2016Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Cancer research
Oncology
Biology
Internal medicine
Gene
Glioma
Genetics
Mutation
Pathology
Surgery
Chemotherapy
Immunotherapy
Regimen
ATRX
Astrocytoma
Bevacizumab
Biochemistry
Cancer
Clinical endpoint
Clinical trial
Enzyme
Ependymoma
Glioblastoma
IDH1
Immunology
Isocitrate dehydrogenase
Phases of clinical research
Adverse effect
Computer science